WallStSmart
BRNS

Barinthus Biotherapeutics plc

NASDAQ: BRNS · HEALTHCARE · BIOTECHNOLOGY

$0.60
-1.66% today

Updated 2026-04-29

Market cap
$26.23M
P/E ratio
P/S ratio
2.17x
EPS (TTM)
$-1.64
Dividend yield
52W range
$1 – $3
Volume
0.0M

Barinthus Biotherapeutics plc (BRNS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-10.2%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-33.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-14.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-26.1%
2025-11-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-20$-0.27+29.8%$0.63$0.61-3.2%
2025-11-07$-0.36+10.0%$1.19$0.88-26.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.39$-0.27+29.8%
2025-09-30$-0.40$-0.36+10.0%
2025-06-30$-0.36$-0.52-44.4%
2025-03-31$-0.36$-0.49-36.1%
2024-12-31$-0.37$-0.20+45.4%$-9.17M-270.9%
2024-09-30$-0.44$-0.21+52.3%$14.97M
2024-06-30$-0.41$-0.43-4.9%
2024-03-31$-0.54$-0.40+25.9%
2023-12-31$-0.50$-0.45+10.0%$5.37M
2023-09-30$-0.53$-0.37+30.2%
2023-06-30$-0.55$-0.62-12.7%$334000.00
2023-03-31$-0.50$-0.48+4.0%$468000.00

Frequently asked questions

Has Barinthus Biotherapeutics plc beaten earnings estimates?
Barinthus Biotherapeutics plc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -10.2% over the last 4 quarters.
How does BRNS stock react to earnings?
BRNS stock has moved an average of -14.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.